" /> Pelizaeus-merzbacher disease - CISMeF





Preferred Label : Pelizaeus-merzbacher disease;

Symbol : PMD;

CISMeF acronym : HLD1; PMD;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Leukodystrophy, hypomyelinating, 1; HLD1;

Description : Pelizaeus-Merzbacher disease is an X-linked recessive hypomyelinative leukodystrophy (HLD1) in which myelin is not formed properly in the central nervous system. PMD is characterized clinically by nystagmus, spastic quadriplegia, ataxia, and developmental delay (Inoue, 2005). - Genetic Heterogeneity of Hypomyelinating Leukodystrophy Other forms of hypomyelinating leukodystrophy include HLD2 (608804), caused by mutation in the GJC2/GJA12 gene (608803) on chromosome 1q41; HLD3 (260600), caused by mutation in the AIMP1 gene (603605) on chromosome 4q24; HLD4 (612233), caused by mutation in the HSPD1 gene (118190) on chromosome 2q33.1; and HLD5 (610532), caused by mutation in the FAM126A gene (610531) on chromosome 7p15.3; HLD6 (612438), caused by mutation in the TUBB4A gene (602662) on chromosome 19p13; HLD7 (607694), caused by mutation in the POLR3A gene (614258) on chromosome 10q22; HLD8 (614381), caused by mutation in the POLR3B gene (614366) on chromosome 12q23; and Allan-Herndon-Dudley syndrome (AHDS; 300523), caused by mutation in the SLC16A2 gene (300095) on chromosome Xq13.;

Inheritance : X-linked recessive;

Molecular basis : Caused by mutation in the proteolipid protein 1 gene (PLP1, 300401.0001);

Prefixed ID : #312080;

Details


You can consult :


Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.